Analysis of pyrimidine synthesis "de novo" intermediates in urine and dried urine filter-paper strips with HPLC-electrospray tandem mass spectrometry

Clinical Chemistry

Volumn 50, Issue 11, 2004, Pages 2117-2124

  Van Kuilenburg, André B P ^a,d   Van Lenthe, Henk ^a   Löffler, Monika ^b   Van Gennip, Albert H ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID DERIVATIVE; DIHYDROOROTIC ACID DERIVATIVE; NITROGEN 15; OROTIC ACID DERIVATIVE; OROTIDINE; PYRIMIDINE; URACIL DERIVATIVE; URIDINE DERIVATIVE;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FILTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METABOLITE; PYRIMIDINE SYNTHESIS; TANDEM MASS SPECTROMETRY; URINALYSIS;

ARGININOSUCCINATE LYASE; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIHYDROURACIL DEHYDROGENASE (NADP); HUMANS; INFANT; INFANT, NEWBORN; ORNITHINE CARBAMOYLTRANSFERASE; PAPER; PYRIMIDINES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 7044247759     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.038869     Document Type: Article

References (24)

1. Huang M, Graves LM. De novo synthesis of pyrimidine nucleotides; emerging interfaces with signal transduction pathways. Cell Mol Life Sci 2003;60:321-36.
2. Christopherson RI, Lyons SD, Wilson PK. Inhibitors of de novo nucleotide biosynthesis as drugs. Acc Chem Res 2002;35:961-71.
3. Ruckemann K, Fairbanks LD, Carrey EA, Hawrylowicz CM, Richards DF, Kirschbaum B, et al. Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 1998;273:21682-91.
4. Bruneau JM, Yea CM, Spinella-Jaegle S, Fudali C, Woodward K, Robson PA, et al. Purification of human dihydro-orotate dehydro-genase and its inhibition by A77 1726, the active metabolite of leflunomide. Biochem J 1998;336(Pt 2):299-303.
5. Webster DR, Becroft DMO, van Gennip AH, van Kuilenburg ABP. Hereditary orotic aciduria and other disorders of pyrimidine metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill Medical Publishing Division, 2001:2663-702.
6. Salerno C, Crifo C. Diagnostic value of urinary orotic acid levels: applicable separation methods. J Chromatogr B Analyt Technol Biomed Life Sci 2002;781:57-71.
7. van Gennip AH, Bree-Blom EJ, Grift J, DeBree PK, Wadman SK. Urinary purines and pyrimidines in patients with hyperammonemia of various origins. Clin Chim Acta 1980;104:227-39.
8. Prescott LM, Jones ME. Modified methods for the determination of carbamyl aspartate. Anal Biochem 1969;32:408-19.
9. Oberholzer VG, Palmer T. Increased excretion of N-carbamoyl compounds in patients with urea cycle defects. Clin Chim Acta 1976;68:73-8.
10. Rogers LE, Nicolaisen K. Enzymatic spectrophotometric assay for dihydroorotic acid in serum and urine. Experientia 1972;28:1258-9.
11. Kesner L, Aronson FL, Silverman M, Chan PC. Determination of orotic and dihydroorotic acids in biological fluids and tissues. Clin Chem 1975;21:353-5.
12. Fairbanks LD, Carrey EA, Ruckemann K, Swaminathan R, Kirschbaum B, Simmonds HA. Simultaneous separation by high-performance liquid chromatography of carbamoyl aspartate, carbamoyl phosphate and dihydroorotic acid. J Chromatogr B Biomed Sci Appl 1999;732:487-93.
13. Hayek-Ouassini M, Henseling J, Löffler M. Separation of N-carbamoyl aspartate and L-dihydroorotate from serum by high-performance liquid chromatography with fluorimetric detection. Chromatographia 2002;55:411-5.
14. Bonham JR, Guthrie P, Downing M, Allen JC, Tanner MS, Sharrard M, et al. The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease. J Inherit Metab Dis 1999;22:174-84.
15. McCann MT, Thompson MM, Gueron IC, Tuchman M. Quantification of orotic acid in dried filter-paper urine samples by stable isotope dilution. Clin Chem 1995;41:739-43.
16. Rashed MS, Jacob M, Al Amoudi M, Rahbeeni Z, Al Sayed MAD, Al Ahaidib L, et al. Rapid determination of orotic acid in urine by liquid chromatography-electrospray tandem mass spectrometry. Clin Chem 2003;49:499-501.
17. Ito T, van Kuilenburg ABP, Bootsma AH, Haasnoot AJ, van Cruchten AG, Wada Y, et al. Rapid screening of high-risk patients for disorders of purine and pyrimidine metabolism using HPLC-electrospray tandem mass spectrometry of liquid urine or urine-soaked filter paper strips. Clin Chem 2000;46:445-52.
18. Salerno C, D'Eufemia P, Celli M, Finocchiaro R, Crifò C, Giardini O. Determination of urinary orotic acid and uracil by capillary zone electrophoresis. J Chromatogr B Biomed Sci Appl 1999;734:175-8.
19. Friedecky D, Adam T, Bartak P. Capillary electrophoresis for detection of inherited disorders of purine and pyrimidine metabolism: a selective approach. Electrophoresis 2002;23:565-71.
20. Nielsen FS, Andersen PS, Jensen KF. The B form of dihydroorotate dehydrogenase from Lactococcus lactis consists of two different subunits, encoded by the pyrDb and pyrK genes, and contains FMN, FAD, and [FeS] redox centers. J Biol Chem 1996;271:29359-65.
21. Henry RJ. Non-protein nitrogenous constituents. Clinical chemistry, principles and techniques. New York: Hoeber Medical Division, Harper & Row, 1964:292-9.
22. Sanders S, Harisdangkul V. Leflunomide for the treatment of rheumatoid arthritis and autoimmunity. Am J Med Sci 2002;323:190-3.
23. Gero AM, O'Sullivan WJ. Purines and pyrimidines in malarial parasites. Blood Cells 1990;16:467-84.
24. van Kuilenburg ABP, Dobritzsch D, Meinsma JR, Haasjes J, Waterham HR, Nowaczyk MJM, et al. Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structure. Biochem J 2002;364:157-63.